PDS Biotechnology

(NASDAQ) PDSB

Current Price$1.08

Market Cap$59.72M

Since IPO (2019)-87%

5 Year-91%

1 Year-22%

1 Month-1%

PDS Biotechnology Financials at a Glance

Market Cap

$59.72M

Revenue (TTM)

$0.00

Net Income (TTM)

-$33.36M

EPS (TTM)

-$0.67

P/E Ratio

-1.60

Dividend

$0.00

Beta (Volatility)

2.01 (High)

Dividend

$0.00

Beta (Volatility)

2.01 (High)

Price

$1.08

Volume

378,307.383

Open

$1.08

Price

$1.08

Volume

378,307.383

Open

$1.08

Previous Close

$1.07

Daily Range

$1.03 - $1.10

52-Week Range

$0.51 - $1.92

Dividend

$0.00

Beta (Volatility)

2.01 (High)

Price

$1.08

Volume

378,307.383

Open

$1.08

Previous Close

$1.07

Daily Range

$1.03 - $1.10

52-Week Range

$0.51 - $1.92

PDSB News

PDSB Loss Improves as Costs Drop

Motley Fool Markets TeamAug 13, 2025

3 Deeply Undervalued Stocks That Could Double Your Money

George Budwell, PhDFeb 15, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PDS Biotechnology

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Frank K. Bedu-Addo, PhD

Website

www.pdsbiotech.com

Headquarters

Princeton, NJ 07932, US

PDSB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-254%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-62.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$59.72M

Shares Outstanding

55.82M

Volume

378.31K

Avg. Volume

908.58K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$31.54M

EBITDA

-$30.30M

Operating Cash Flow

-$27.75B

Capital Expenditure

$0.00

Free Cash Flow

-$27.75B

Cash & ST Invst.

$26.71M

Total Debt

$16.93M

PDS Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$59.72M

N/A

Market Cap/Employee

$2.49M

N/A

Employees

N/A

Net Income

-$7.35M

+13.4%

EBITDA

-$6.52M

+25.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$5.80M

-72.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$10.62M

+66.0%

Short Term Debt

$5.24M

-58.3%

Return on Assets

-1.35%

N/A

Return on Invested Capital

-1.99%

N/A

Free Cash Flow

-$4.37B

-48300.4%

Operating Cash Flow

-$4.37B

-48300.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OKUROnKure Therapeutics, Inc.

OKUROnKure Therapeutics, Inc.$4.29+4.13%

KZRKezar Life Sciences, Inc.

KZRKezar Life Sciences, Inc.$7.29+0.00%

XLOXilio Therapeutics, Inc.

XLOXilio Therapeutics, Inc.$8.27-2.93%

LVTXLAVA Therapeutics N.V.

LVTXLAVA Therapeutics N.V.$1.74-3.87%

ANVSAnnovis Bio, Inc.

ANVSAnnovis Bio, Inc.$1.95+2.36%

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

INMBINmune Bio, Inc.

INMBINmune Bio, Inc.$1.37-3.87%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FFord Motor Company

FFord Motor Company$17.43+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.98-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$84.62+0.01%

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$43.41+0.14%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.05-0.01%

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF$7.17+0.27%

DELLDell Technologies

DELLDell Technologies$407.00+0.28%

Questions About PDSB

What is the current price of PDS Biotechnology?

PDS Biotechnology is trading at $1.08 per share.

What is the 52-week range for PDS Biotechnology?

Over the past 52 weeks, PDS Biotechnology has traded between $0.51 and $1.92.

How much debt does PDS Biotechnology have?

As of the most recent reporting period, PDS Biotechnology reported total debt of $15.86M.

How much cash does PDS Biotechnology have on hand?

PDS Biotechnology reported $21.66M in cash and cash equivalents in its most recent financial results.

What is PDS Biotechnology’s dividend yield?

PDS Biotechnology does not currently have a dividend yield.

PDS Biotechnology

PDS Biotechnology Financials at a Glance

PDSB News

PDSB Loss Improves as Costs Drop

3 Deeply Undervalued Stocks That Could Double Your Money

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About PDS Biotechnology

PDSB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

PDS Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PDSB

What is the current price of PDS Biotechnology?

What is the 52-week range for PDS Biotechnology?

How much debt does PDS Biotechnology have?

How much cash does PDS Biotechnology have on hand?

What is PDS Biotechnology’s dividend yield?

Premium Investing Services